Senior Partner (IP Litigation), Paul Harris has written an article featured by LexisNexis; 'Colours are not indicative of manufacturer, but of drug class (Glaxo Wellcome UK Ltd and another v Sandoz Ltd)'. This article was first published by Lexis®PSL on 10/10/2019.

Senior Partner (IP Litigation), Paul Harris has written an article featured by LexisNexis; ‘Colours are not indicative of manufacturer, but of drug class (Glaxo Wellcome UK Ltd and another v Sandoz Ltd)’. This article was first published by Lexis®PSL on 10/10/2019.

To view the full article, please press ‘download’ below or click here to view the article online.